These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7476093)

  • 41. Aerobic exercise attenuates pulmonary inflammation induced by Streptococcus pneumoniae.
    Olivo CR; Miyaji EN; Oliveira ML; Almeida FM; Lourenço JD; Abreu RM; Arantes PM; Lopes FD; Martins MA
    J Appl Physiol (1985); 2014 Nov; 117(9):998-1007. PubMed ID: 25190745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of two serological methods and a polymerase chain reaction-enzyme immunoassay for the diagnosis of acute respiratory infections with Chlamydia pneumoniae in adults.
    Petitjean J; Vincent F; Fretigny M; Vabret A; Poveda JD; Brun J; Freymuth F
    J Med Microbiol; 1998 Jul; 47(7):615-21. PubMed ID: 9839566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae.
    Bandholtz L; Kreuger MR; Svanholm C; Wigzell H; Rottenberg ME
    Clin Exp Immunol; 2002 Dec; 130(3):393-403. PubMed ID: 12452828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of acute Chlamydia pneumoniae infection on lipoprotein metabolism in NIH/S mice.
    Tiirola T; Erkkilä L; Laitinen K; Leinonen M; Saikku P; Bloigu A; Jauhiainen M
    Scand J Clin Lab Invest; 2002; 62(6):477-84. PubMed ID: 12469903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nuclear factor-kappaB activation in mouse lung lavage cells in response to Streptococcus pneumoniae pulmonary infection.
    Amory-Rivier CF; Mohler J; Bédos JP; Azoulay-Dupuis E; Henin D; Muffat-Joly M; Carbon C; Moine P
    Crit Care Med; 2000 Sep; 28(9):3249-56. PubMed ID: 11008989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The resistance of human monocyte-derived macrophages to Chlamydia pneumoniae infection is enhanced by interferon-gamma.
    Airenne S; Surcel HM; Bloigu A; Laitinen K; Saikku P; Laurila A
    APMIS; 2000 Feb; 108(2):139-44. PubMed ID: 10737459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice.
    Marangoni A; Fiorino E; Gilardi F; Aldini R; Scotti E; Nardini P; Foschi C; Donati M; Montagnani M; Cevenini M; Franco P; Roda A; Crestani M; Cevenini R
    Atherosclerosis; 2015 Aug; 241(2):471-9. PubMed ID: 26086356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma.
    Rothfuchs AG; Kreuger MR; Wigzell H; Rottenberg ME
    J Immunol; 2004 Feb; 172(4):2407-15. PubMed ID: 14764711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum reactivity to Chlamydia trachomatis and C. pneumoniae antigens in patients with documented infection and in healthy children by microimmunofluorescence and immunoblotting techniques.
    Gonen R; Shemer-Avni Y; Csángó PA; Sarov B; Friedman MG
    APMIS; 1993 Sep; 101(9):719-26. PubMed ID: 8240791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease.
    Mendall MA; Carrington D; Strachan D; Patel P; Molineaux N; Levi J; Toosey T; Camm AJ; Northfield TC
    J Infect; 1995 Mar; 30(2):121-8. PubMed ID: 7636277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chlamydia pneumoniae--pathogenesis and perspectives].
    Berdal BP; Scheel O
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):859-61. PubMed ID: 8480296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection.
    Morrison SG; Morrison RP
    J Immunol; 2005 Dec; 175(11):7536-42. PubMed ID: 16301662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serological response to Chlamydia pneumoniae in patients with sarcoidosis.
    Puolakkainen M; Campbell LA; Kuo CC; Leinonen M; Grönhagen-Riska C; Saikku P
    J Infect; 1996 Nov; 33(3):199-205. PubMed ID: 8945710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection.
    Murdin AD; Dunn P; Sodoyer R; Wang J; Caterini J; Brunham RC; Aujame L; Oomen R
    J Infect Dis; 2000 Jun; 181 Suppl 3():S544-51. PubMed ID: 10839756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibodies against Chlamydia pneumoniae and their relation to lymphocyte population levels.
    González-Castañeda C; Pérez-Castrillón JL; Romero-Gómez M; Herreros-Fernández V
    Int J Cardiol; 2002 Mar; 82(3):293-5. PubMed ID: 11911918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population.
    Gaydos CA; Fowler CL; Gill VJ; Eiden JJ; Quinn TC
    Clin Infect Dis; 1993 Oct; 17(4):718-23. PubMed ID: 8268355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell mediated immunity to Chlamydia pneumoniae.
    Halme S; Surcel HM
    Scand J Infect Dis Suppl; 1997; 104():18-21. PubMed ID: 9259075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute Chlamydia pneumoniae reinfection accelerates the development of insulin resistance and diabetes in obese C57BL/6 mice.
    Wang C; Gao D; Kaltenboeck B
    J Infect Dis; 2009 Jul; 200(2):279-87. PubMed ID: 19508161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chlamydia pneumoniae infection suppresses Staphylococcus enterotoxin B-induced proliferation associated with down-expression of CD25 in lymphocytes.
    Hirai I; Utsumi M; Yamaguchi H; Yamamoto Y
    Can J Microbiol; 2010 Apr; 56(4):289-94. PubMed ID: 20453895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Bacterial flora from bronchoalveolar lavage and occurrence of class IgG and IgA antibodies to Chlamydia pneumoniae in patients with chronic obstructive pulmonary disease (COPD)].
    Chylak J; Michalska W; Paul M; Wengerek-Kołaczkowska M; Młynarczyk W
    Med Dosw Mikrobiol; 2002; 54(3):259-64. PubMed ID: 12632661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.